4.7 Article

Protection of ZIKV infection-induced neuropathy by abrogation of acute antiviral response in human neural progenitors

Journal

CELL DEATH AND DIFFERENTIATION
Volume 26, Issue 12, Pages 2607-2621

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41418-019-0324-7

Keywords

-

Funding

  1. National Key Research and Development Program of China [2018YFA0108000]
  2. National Natural Science foundation of China [31771132, 31872760, 31301157, 31400934, 81471397, 31601908]
  3. National Science and Technology Major Project [2016YFD0500208, 2017ZX10304402001012, 2017ZX10304402001006]
  4. Shanghai Municipal Education Commission [C120114]
  5. Fundamental Research Funds for the Central Universities
  6. Major Program of Development Fund for Shanghai Zhangjiang National Innovation Demonstration Zone (Stem Cell Strategic Biobank) [ZJ2018-ZD-004]
  7. Major Program of Development Fund for Shanghai Zhangjiang National Innovation Demonstration Zone (Clinical Translation Platform of Stem Cell Technology) [ZJ2018-ZD-004]

Ask authors/readers for more resources

It remains largely unknown how Zika virus (ZIKV) infection causes severe microcephaly in human newborns. We examined an Asian lineage ZIKV, SZ01, which similarly infected and demonstrated comparable growth arrest and apoptotic pathological changes in human neuroprogenitors (NPCs) from forebrain dorsal, forebrain ventral as well as hindbrain and spinal cord brain organoids derived from human pluripotent stem cells. Transcriptome profiling showed common overactivated antiviral response in all regional NPCs upon ZIKV infection. ZIKV infection directly activated a subset of IFN-stimulated genes (ISGs) in human NPCs, which depended on the presence of IRF3 and NF-kappa B rather than IFN production and secretion, highlighting a key role of IFN-independent acute antiviral pathway underlying ZIKV infection-caused neuropathy. Our findings therefore reveal that overactivated antiviral response is detrimental rather than protective in human NPCs, and the IFN-independent acute antiviral pathway may serve as a potential target to ameliorate ZIKV infection-triggered neuropathy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available